Arkolith/Insider Trading/CELU/Form 4

Kilcoyne Adrian

Chief Medical OfficerCelularity Inc (CELU) · full profile →Form 4 · filed Feb 21, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2024Tax withholding(F)53K$0.43$23K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 16, 2024Grant(A)205K—$0205K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-007487) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML